Using Transgenic Mouse to Generate Human Antibodies
Closed Pre-Solicitation Posted
- Solicitation number
- RFI-62675
- Agency
- CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- Not on record
- Place of performance
- Atlanta, Georgia 30341, United States
Notice details come from SAM.gov. Updated .
Notice text
CDC seeks to test a transgenic mouse model that is engineered with human immunoglobulin gene segments to produce humanized antibodies, with the goal of determining if the antibodies generated from that mouse model can better recapitulate the antibody repertoire from humans.
Overall objective is to provide the Influenza Division with transgenic mice that express human antibody repertoire, which would be useful for assessing the efficacy of Candidate Vaccine Viruses (CVVs) and developing antibodies.
Attachments
| File | Type | Posted |
|---|---|---|
| A1.b_Statement of Work.docx | DOCX document |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity